145105-06-2

Usage

Uses

Used in Pharmaceutical Research:
Pyridine, 4-[1-(phenylmethyl)-3-pyrrolidinyl]is used as a potential ligand or building block for bioactive molecules in medicinal chemistry. Its unique structure allows it to be a key component in the design and synthesis of new drugs, potentially leading to advancements in the treatment of various diseases and conditions.
Used in Organic Synthesis:
In the field of organic synthesis, Pyridine, 4-[1-(phenylmethyl)-3-pyrrolidinyl]is employed as an intermediate or a reagent in the preparation of more complex molecules. Its presence in the synthesis process can contribute to the creation of novel compounds with specific properties and applications.
Used in Agrochemicals:
Pyridine, 4-[1-(phenylmethyl)-3-pyrrolidinyl]may also find applications in the agrochemical industry, where it could be used as a component in the development of new pesticides, herbicides, or other agricultural chemicals. Its potential role in this field highlights the compound's versatility and the broad range of industries it can impact.
Used in Materials Science:
In materials science, Pyridine, 4-[1-(phenylmethyl)-3-pyrrolidinyl]could be utilized in the development of new materials with specific properties, such as improved conductivity, stability, or reactivity. Its incorporation into materials could lead to innovations in various applications, from electronics to environmental protection.

Upstream product

• 100-46-9 benzylamine 
• 100-43-6 4-vinylpyridine 
• 93102-05-7 N-benzyl-N-(methoxymethyl)-N-[(trimethylsilyl)methyl]amine 

Downstream Products

• 1024590-32-6 4-(N-tert-butoxycarbonylpyrrolidin-3-yl)pyridine 
• 1024590-31-5 N-(N-benzypyrrolidin-3-yl)piperidine 
• 150281-47-3 4-pyrrolidin-3-yl-pyridine 

Relevant academic research and scientific papers

Synthesis of 3-substituted pyrrolidines

A method was developed for the synthesis of derivatives of 3-substituted pyrrolidines from activated alkenes by 1,3-dipolar cycloaddition of unstable 2-benzylazomethylide, generated in situ from N-benzyl-N-(methoxymethyl)-N- (trimethylsilyl)amine. A method was developed for the reduction of 4-(3-pyrrolidyl)pyridine, prepared by the above-mentioned method, to the corresponding derivatives of (3-pyrrolidyl)piperidine with high yields under mild conditions.

Rifamycin derivatives

Novel rifamycin derivatives of formula I (both hydroquinone and corresponding quinone (C1-C4) forms): or their salts, hydrates or prodrugs thereof, wherein: a preferred R comprises hydrogen, acetyl; L is a linker, a preferred linker group elements selected from any combination of 1 to 5 groups shown FIG. 1, provided L is not wherein R1 is H, methyl or alkyl. The inventive compounds exhibit valuable antibiotic properties. Formulations having these compounds can be used in the control or prevention of infectious diseases in mammals, both humans and non-humans. In particular, the compounds exhibit a pronounced antibacterial activity, even against multiresistant strains of microbes.

7-substituted quinolones and naphthyridones as antibacterial agents

7-Substituted quinolones and naphthyridones are described as antibacterial agents as well as a process for their manufacture, compositions therefor, wherein the 7-substituent is a pyrrolidine ring substituted at the 3-position by a substituted aromatic hydrocarbon or a heteroaromatic group.

3-Arylpyrrolidines via azomethine ylide 1,3-dipolar cycloaddition to styrenes

Monosubstituted olefins conjugated to an aromatic or heteroaromatic ring undergo 1,3-dipolar cycloaddition with the azomethie ylide derived from N-benzyl-N-(methoxymethyl)trimethylsilylamine to give 3-aryl- and 3-hetero-arylpyrrolidines in good to excellent yield.